| ID | Age | Sex | State | Date โผ | Onset Days | Vaccine | Manufacturer | Lot # | Symptoms | Narrative | ๐ | ๐ฅ | ๐ | โฟ | โ ๏ธ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2827985 | 20 | F | KY | 02/25/2025 |
HEP |
GLAXOSMITHKLINE BIOLOGICALS |
42B22 |
Underdose
Underdose
|
dose 1 given was a pediatric dose; dose 1 given was a pediatric dose; This non-serious case was repo...
dose 1 given was a pediatric dose; dose 1 given was a pediatric dose; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of underdose in a 20-year-old female patient who received HBV (Engerix B pediatric) (batch number 42B22, expiry date 07-MAR-2026) for prophylaxis. On 25-JUL-2024, the patient received the 1st dose of Engerix B pediatric. On 25-JUL-2024, an unknown time after receiving Engerix B pediatric, the patient experienced underdose (Verbatim: dose 1 given was a pediatric dose) and adult use of a child product (Verbatim: dose 1 given was a pediatric dose). The outcome of the underdose and adult use of a child product were not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 30-JAN-2025 The pharmacist reported that 21 year old female patient was in pharmacy requesting third dose of Engerix-B series. The first two doses were administered at another facility. Upon looking at the records, dose 1 was given was a pediatric dose which led to underdose and adult use of a child product. On 27th August 2024, dose 2 was given was an adult dose. The patient was 20 years old at the time of both doses. At the time of call, the pharmacist had not yet administered a third dose.
More
|
||||||
| 2827986 | 78 | F | AL | 02/25/2025 |
COVID19 COVID19 |
MODERNA MODERNA |
|
Atrial fibrillation, Blood disorder, Cerebral thrombosis, Cerebrovascular accide...
Atrial fibrillation, Blood disorder, Cerebral thrombosis, Cerebrovascular accident, Death; Fluid retention
More
|
developed atrial fibrillation/atrial fibrillation worsened; stroke; blood clot was found in her brai...
developed atrial fibrillation/atrial fibrillation worsened; stroke; blood clot was found in her brain; having blood issues after her first vaccine; we lost her; she started retaining water 2 weeks before we lost her; This spontaneous case was reported by a patient family member or friend and describes the occurrence of DEATH (we lost her), ATRIAL FIBRILLATION (developed atrial fibrillation/atrial fibrillation worsened), CEREBROVASCULAR ACCIDENT (stroke) and CEREBRAL THROMBOSIS (blood clot was found in her brain) in a 78-year-old female patient who received SPIKEVAX NOS (SPIKEVAX NOS) for COVID-19 prophylaxis. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On an unknown date, the patient received first dose of SPIKEVAX NOS (SPIKEVAX NOS) (Intramuscular use) 1 dosage form. On an unknown date, received second dose of SPIKEVAX NOS (SPIKEVAX NOS) (Intramuscular use) dosage was changed to 1 dosage form and third dose of SPIKEVAX NOS (SPIKEVAX NOS) (Intramuscular use) dosage was changed to 1 dosage form. In August 2022, the patient experienced FLUID RETENTION (she started retaining water 2 weeks before we lost her). On an unknown date, the patient experienced ATRIAL FIBRILLATION (developed atrial fibrillation/atrial fibrillation worsened) (seriousness criterion medically significant), CEREBROVASCULAR ACCIDENT (stroke) (seriousness criterion medically significant), CEREBRAL THROMBOSIS (blood clot was found in her brain) (seriousness criterion medically significant) and BLOOD DISORDER (having blood issues after her first vaccine). The patient died on 14-Sep-2022. The cause of death was not reported. It is unknown if an autopsy was performed. At the time of death, ATRIAL FIBRILLATION (developed atrial fibrillation/atrial fibrillation worsened), CEREBROVASCULAR ACCIDENT (stroke), CEREBRAL THROMBOSIS (blood clot was found in her brain), FLUID RETENTION (she started retaining water 2 weeks before we lost her) and BLOOD DISORDER (having blood issues after her first vaccine) outcome was unknown. Concomitant medication was not reported. Patient started having blood issues after her first vaccine. After her second vaccine she developed atrial fibrillation issues and was rushed to the emergency room for a stroke, and a blood clot was found in her brain. After the third vaccine the atrial fibrillation worsened, and she started retaining water 2 weeks before her death. It was unknown if the patient experienced any additional symptoms/events. Treatment medication was not reported.; Reporter's Comments: Company comment: The benefit-risk relationship of product is not affected by this report.; Reported Cause(s) of Death: we lost her
More
|
โ | |||||
| 2827987 | NY | 02/25/2025 |
DTPPVHBHPB |
MSP VACCINE COMPANY |
U7907AA |
Extra dose administered
Extra dose administered
|
administered a 4th dose of the vaccine on 10/21/2024 while they were 9 months old. Nurse confirmed t...
administered a 4th dose of the vaccine on 10/21/2024 while they were 9 months old. Nurse confirmed the patient adhered to the 3 dose series of VAXELIS, but were inadvertently administered a 4th dose.; administered a 4th dose of the vaccine on 10/21/2024 while they were 9 months old. Nurse confirmed the patient adhered to the 3 dose series of VAXELIS, but were inadvertently administered a 4th dose.; administered a 4th dose of the vaccine on 10/21/2024 while they were 9 months old. Nurse confirmed the patient adhered to the 3 dose series of VAXELIS, but were inadvertently administered a 4th dose.; This non-serious spontaneous safety report, with reference number 02739314 (interaction number: 02739305), was received by partner on 21-JAN-2025 and forwarded to agency on 21-JAN-2025 from other health professional. Off-label classification was added due to Vaxelis being administered to a 9-month-old patient. Due to the nature of the event, the causality between the events 'administered a 4th dose of the vaccine on 10/21/2024 while they were 9 months old. Nurse confirmed the patient adhered to the 3 dose series of VAXELIS but were inadvertently administered a 4th dose' and Vaxelis was not applicable. Further information is expected.
More
|
||||||||
| 2827989 | 66 | M | MT | 02/25/2025 |
COVID19 |
PFIZER\BIONTECH |
|
Cardiac amyloidosis, Carpal tunnel syndrome, Magnetic resonance imaging heart, M...
Cardiac amyloidosis, Carpal tunnel syndrome, Magnetic resonance imaging heart, Muscle injury, Tendon rupture
More
|
Patient received Pfizer covid 19 vaccine doses on 2/5/21 and 2/26/21. Following those Pfizer Covid 1...
Patient received Pfizer covid 19 vaccine doses on 2/5/21 and 2/26/21. Following those Pfizer Covid 19 doses patient experienced bilateral bicep tears, bilateral ham [INVALID]te, and bilateral carpal tunnel syndromes. Patient was concerned about possible amyloidosis following these symptoms as muscle and carpal tunnel manifestations are known complications of amyloidosis. In August of 2023 (~18 months follow covid vaccine doses) he was diagnosed with cardiac amyloidosis. Case reports of covid 19 vaccine induced amyloidosis are available in published literature.
More
|
โ | |||||
| 2827990 | 35 | M | NY | 02/25/2025 |
TDAP |
GLAXOSMITHKLINE BIOLOGICALS |
x449y |
Hypoaesthesia, Paraesthesia
Hypoaesthesia, Paraesthesia
|
Patient states they have arm tingling and numbness radiating through their shoulder into their finge...
Patient states they have arm tingling and numbness radiating through their shoulder into their fingers on the arm the vaccine was administered. it has been over 4 months since then and it still comes and goes, has not gotten better.
More
|
โ | |||||
| 2827991 | F | IN | 02/25/2025 |
COVID19 |
MODERNA |
|
Computerised tomogram abnormal, Lymphadenopathy, Neoplasm
Computerised tomogram abnormal, Lymphadenopathy, Neoplasm
|
I am a 56 y/o woman with a history of Type 1 Diabetes (LADA) Lupus, Stage 3A Kidney Disease, Non-Alc...
I am a 56 y/o woman with a history of Type 1 Diabetes (LADA) Lupus, Stage 3A Kidney Disease, Non-Alcoholic Cirrhosis of the Liver and Breast Cancer. After receiving my second Moderna vaccination for Covid 19, (that made me so ill I spent close to a week in bed) I noticed that the lymph nodes on the underneath side of my arms from my armpits down and my groin, became swollen and dense feeling. I put it down to being chronically sick. However, when I mentioned it to my endocrinologist literally a few years later, she ordered a CT scan. It showed lymph nodes of various sizes with flow, having fatty hilums. ranging from 0.5 to 2.5 cm The lymph nodes have times when they slightly reduced in size only to come back and get larger. They currently feel the largest they have even been. Especially in the armpit next to the breast where I had my lumpectomy and radiation treatment for breast cancer. I have an MRI scheduled for 2/25/25. It is for a couple of different things, but my endocrinologist will be looking at the state of my lymph nodes. Having had cancer and still having several tumors is what is concerning to my doctor. There lines of swollen lymph nodes never existed prior to the Moderna Covid vaccination, which I received approximately 4/21 from the pharmacy at our local store. Although I have many co-morbid conditions, permanently swollen lymph nodes were never one of them. I would like to know if the Moderna vaccination indeed caused this, and will this do me further harm given my medical history of cancer and currently having multiple tumors? Knowledge is power and staying on top of my medical conditions is imperative. I'm sure that is understandable. Thank you for your time and consideration We will find out after the 25th if there are additional changes to the lymph nodes and the existing tumors.
More
|
โ | ||||||
| 2827992 | F | MI | 02/25/2025 |
RSV |
GLAXOSMITHKLINE BIOLOGICALS |
|
Stevens-Johnson syndrome
Stevens-Johnson syndrome
|
I received a GSK RSV vaccine and had a late onset reaction that turned out to be SJS I went to Urgen...
I received a GSK RSV vaccine and had a late onset reaction that turned out to be SJS I went to Urgent Care Clinic and no test was performed.
More
|
โ | ||||||
| 2827993 | 55 | M | MI | 02/25/2025 |
COVID19 |
PFIZER\BIONTECH |
|
Alpha-1 antitrypsin deficiency, Chronic lymphocytic leukaemia
Alpha-1 antitrypsin deficiency, Chronic lymphocytic leukaemia
|
Since taking the first two Covid vaccines, I have been diagnosed with alpha 1 antitrypsen deficiency...
Since taking the first two Covid vaccines, I have been diagnosed with alpha 1 antitrypsen deficiency (no family history) and chronic lymphocytic leukemia. Perfectly health prior to Covid.
More
|
โ | |||||
| 2827994 | 12 | M | FL | 02/25/2025 |
HPV9 |
MERCK & CO. INC. |
|
Dysphagia, Facial paralysis, Hypoaesthesia, Mastication disorder, Paraesthesia
Dysphagia, Facial paralysis, Hypoaesthesia, Mastication disorder, Paraesthesia
|
The evening after the vaccine, pt. began to feel tingling sensation in left cheek and jaw, the follo...
The evening after the vaccine, pt. began to feel tingling sensation in left cheek and jaw, the following day at school his friends noted his "uneven facies, left side drooping", mom then noted significant facial differences when she saw him after school that day and took him straight to ER. There they performed a physical exam and labs. His vital signs and labs were normal, face was still numb on left side, weak with inability to smile and fully close left eye, mild difficulty chewing and swallowing. Per mother's report the providers at the ER did not feel that imaging was necessary. He was sent home on a oral steroid wean. When seen in PCP office on 2/22/25, weakness and numbness per
More
|
||||||
| 2827995 | 1 | M | MA | 02/25/2025 |
MMRV PNC20 VARCEL |
MERCK & CO. INC. PFIZER\WYETH MERCK & CO. INC. |
Y017205 HR3650 Y011020 |
Unevaluable event; Unevaluable event; Unevaluable event
Unevaluable event; Unevaluable event; Unevaluable event
|
None reported at this time
None reported at this time
|
||||||
| 2828031 | 40 | M | CA | 02/25/2025 |
COVID19 |
PFIZER\BIONTECH |
|
Ageusia, Anosmia, Magnetic resonance imaging
Ageusia, Anosmia, Magnetic resonance imaging
|
Complete loss of taste and smell for more than two years. Smell and taste never went back to normal...
Complete loss of taste and smell for more than two years. Smell and taste never went back to normal.
More
|
โ | |||||
| 2828032 | 54 | F | SD | 02/25/2025 |
COVID19 COVID19 COVID19 |
PFIZER\BIONTECH PFIZER\BIONTECH PFIZER\BIONTECH |
EH9899 EL3246 FH8028 |
Ear congestion, Persistent postural-perceptual dizziness, Tinnitus, Vertigo posi...
Ear congestion, Persistent postural-perceptual dizziness, Tinnitus, Vertigo positional; Ear congestion, Persistent postural-perceptual dizziness, Tinnitus, Vertigo positional; Ear congestion, Persistent postural-perceptual dizziness, Tinnitus, Vertigo positional
More
|
Fullness in ears happened within an hour after first shot. Tinnitus started a few days later and ca...
Fullness in ears happened within an hour after first shot. Tinnitus started a few days later and came and went at first becoming more frequent and the volume increasing after the second shot one month later. It didn't come and go after that, it just remained. I don't remember a change after the 3rd shot but the tinnitus is now permanent and loud. I am now dealing with BPPV and PPPD and constant tinnitus.
More
|
||||||
| 2828033 | 61 | M | MI | 02/25/2025 |
COVID19 COVID19 |
MODERNA MODERNA |
018b21a 043b21a |
Excessive cerumen production, Tinnitus; Excessive cerumen production, Tinnitus
Excessive cerumen production, Tinnitus; Excessive cerumen production, Tinnitus
|
Noticeable ringing in ears. Thought I had a wax plug so went to doctor to have ears checked out. D...
Noticeable ringing in ears. Thought I had a wax plug so went to doctor to have ears checked out. During visit had a hearing exam. Noted to technician that I had ringing in my ears. Having worked in an industry that demanded hearing tests yearly, I knew that driving, which I had to drive 60 miles to appointment, may cause some hearing distortion. The doctor was also told of the ringing in the ears but no mention was made except for ear leaning. After visit and continuing on till today, the tinnitus remains. There is no relief able to be provided. As mentioned, I wore hearing protection every day and my hearing tests performed provided no abnormal impacts to hearing. The tinnitus did not occur during my working career.
More
|
||||||
| 2828034 | 10 | F | GA | 02/25/2025 |
HEPA |
GLAXOSMITHKLINE BIOLOGICALS |
SKBT5727 |
Pruritus, Urticaria
Pruritus, Urticaria
|
400pm developed localized left arm only urticaria and itching
400pm developed localized left arm only urticaria and itching
|
||||||
| 2828035 | 70 | M | SC | 02/25/2025 |
PNC20 |
PFIZER\WYETH |
lj5283 |
Extra dose administered
Extra dose administered
|
patient received a second dose of vaccine after having received a dose less than 2 years ago. vaccin...
patient received a second dose of vaccine after having received a dose less than 2 years ago. vaccines given too close together
More
|
||||||
| 2828036 | 46 | F | GA | 02/25/2025 |
HEP MMR |
DYNAVAX TECHNOLOGIES CORPORATION MERCK & CO. INC. |
944917 X026222 |
Fatigue, Flushing, Product preparation error, Rash, Vision blurred; Fatigue, Flu...
Fatigue, Flushing, Product preparation error, Rash, Vision blurred; Fatigue, Flushing, Product preparation error, Rash, Vision blurred
More
|
After administration of MMR vaccine subcutaneous to the left upper arm, noticed the MMR vaccine had ...
After administration of MMR vaccine subcutaneous to the left upper arm, noticed the MMR vaccine had been reconstituted with the HEPLISAV-B vaccine instead of the sterile diluent. Subcutaneous injection was given at 11:30 AM. At 11:45 AM began c/o feeling flushed, slight blurry vision, rash noticed on bilateral sides of neck and on upper right scapula. Denied any symptoms of Anaphylaxis. 11:56 AM VS: BP 151/95 Pulse 75 Resp 16 O2 sat 98%. 12:05 PM Diphenhydramine 50 mg IM. 1225 rash and flushing has disappeared. Pt is feeling drowsy from the Benadryl injection. VSS. Monitored pt until daughter came to clinic to take her home. Pt denies any symptoms upon leaving with the exception of tiredness. Pt ambulated with assistance of RN to daughter's vehicle. Advised pt and daughter if patient were to experience any anaphylactic symptoms such as difficulty breathing, lip or tongue swelling or any other emergent conditions to report to the nearest emergency room for evaluation. Pt vitals upon clinic discharge at 1405 were: BP 134/83 heart rate 78, respirations 16, 02 sat 98%.
More
|
||||||
| 2828037 | 64 | M | GA | 02/25/2025 |
FLU3 |
GLAXOSMITHKLINE BIOLOGICALS |
K72S4 |
Extra dose administered, No adverse event
Extra dose administered, No adverse event
|
This dose of the influenza vaccine was administered on 1/30/2025. Unfortunately, the nurse administe...
This dose of the influenza vaccine was administered on 1/30/2025. Unfortunately, the nurse administering the vaccine was unaware that the patient received a previous dose of the influenza vaccine on 1/02/2025. The patient had no symptoms, treatment was not required, and there were no adverse outcomes.
More
|
||||||
| 2828038 | 9 | F | TX | 02/25/2025 |
MMR |
MERCK & CO. INC. |
X004346 |
Expired product administered, No adverse event
Expired product administered, No adverse event
|
Gave an expired MMR vaccine to child. MMR vaccine expired on 02/08/2025 and it was given on 02/20/20...
Gave an expired MMR vaccine to child. MMR vaccine expired on 02/08/2025 and it was given on 02/20/2025. No adverse reactions noted.
More
|
||||||
| 2828039 | 77 | F | 02/25/2025 |
VARZOS |
GLAXOSMITHKLINE BIOLOGICALS |
3ext9 |
Erythema, Peripheral swelling, Rash, Swelling face
Erythema, Peripheral swelling, Rash, Swelling face
|
Pt had severe reaction post vaccination for about 3 weeks. Their arm was red and swollen, then about...
Pt had severe reaction post vaccination for about 3 weeks. Their arm was red and swollen, then about 2-3 weeks after vaccination she developed a red rash on her face with some swelling.
More
|
|||||||
| 2828040 | 15 | F | TX | 02/25/2025 |
FLU3 HEP HEPA IPV MMR MNQ TDAP VARCEL |
GLAXOSMITHKLINE BIOLOGICALS MERCK & CO. INC. MERCK & CO. INC. SANOFI PASTEUR MERCK & CO. INC. SANOFI PASTEUR GLAXOSMITHKLINE BIOLOGICALS MERCK & CO. INC. |
J245K X024135 X025908 W1C831M X004346 U7827AA H95RD X024649 |
Expired product administered, No adverse event; Expired product administered, No...
Expired product administered, No adverse event; Expired product administered, No adverse event; Expired product administered, No adverse event; Expired product administered, No adverse event; Expired product administered, No adverse event; Expired product administered, No adverse event; Expired product administered, No adverse event; Expired product administered, No adverse event
More
|
Gave an expired MMR vaccine to child. MMR vaccine expired on 02/08/2025 and it was given on 02/20/20...
Gave an expired MMR vaccine to child. MMR vaccine expired on 02/08/2025 and it was given on 02/20/2025. No adverse reactions noted.
More
|
||||||
| 2828041 | 27 | M | VA | 02/25/2025 |
IPV MMR |
SANOFI PASTEUR MERCK & CO. INC. |
Y1A201M Y010372 |
Fall, Head injury, Syncope; Fall, Head injury, Syncope
Fall, Head injury, Syncope; Fall, Head injury, Syncope
|
PT FAINTED 2-3 MINS AFTER ADMINISTRATION, HE WAS WALKING AWAY THEN FELL AND HIT HIS HEAD ON THE GROU...
PT FAINTED 2-3 MINS AFTER ADMINISTRATION, HE WAS WALKING AWAY THEN FELL AND HIT HIS HEAD ON THE GROUND.
More
|
||||||
| 2828042 | 42 | F | OH | 02/25/2025 |
RAB |
SANOFI PASTEUR |
X1D401M |
Fatigue, Lymphadenopathy, Pyrexia
Fatigue, Lymphadenopathy, Pyrexia
|
Fatigue began 2/20/2025 and lasted through 2/21/2025. Reported fever in the middle of the night 2/20...
Fatigue began 2/20/2025 and lasted through 2/21/2025. Reported fever in the middle of the night 2/20/25-2/21/25 that broke by morning, never took temperature. Reported waking up with a lima bean sized swollen lymph node on the morning of 2/21/25. Lymph node remains swollen but decreasing on 2/25/2025.
More
|
||||||
| 2828043 | 21 | F | ME | 02/25/2025 |
RSV |
PFIZER\WYETH |
LN5502 |
Exposure during pregnancy, No adverse event, Product storage error
Exposure during pregnancy, No adverse event, Product storage error
|
Out of range temperature for refrigerator. No adverse reactions.
Out of range temperature for refrigerator. No adverse reactions.
|
||||||
| 2828044 | 25 | F | ME | 02/25/2025 |
RSV |
PFIZER\WYETH |
LN5502 |
Exposure during pregnancy, No adverse event, Product storage error
Exposure during pregnancy, No adverse event, Product storage error
|
Out of range temperature for refrigerator. No adverse reactions
Out of range temperature for refrigerator. No adverse reactions
|
||||||
| 2828045 | 64 | M | 02/25/2025 |
VARZOS |
GLAXOSMITHKLINE BIOLOGICALS |
YZ9CY |
Chills, Extra dose administered, Myalgia, Pyrexia, Urticaria
Chills, Extra dose administered, Myalgia, Pyrexia, Urticaria
|
Patient reported experiencing fever, chills, hives, and myalgia approximately 48-72 hr after receivi...
Patient reported experiencing fever, chills, hives, and myalgia approximately 48-72 hr after receiving a third Shingrix dose. Previous doses 1&2 of Shingrix were administered in 2022.
More
|
|||||||
| 2828046 | 43 | F | ME | 02/25/2025 |
TDAP |
SANOFI PASTEUR |
U7904AA |
No adverse event, Product storage error
No adverse event, Product storage error
|
Out of range temperature for refrigerator. No adverse reactions
Out of range temperature for refrigerator. No adverse reactions
|
||||||
| 2828047 | 85 | F | ME | 02/25/2025 |
FLU3 |
SANOFI PASTEUR |
UT9409EA |
Product storage error
Product storage error
|
It was discovered after vaccine was given, that the refrigerator it was kept in was out of temperatu...
It was discovered after vaccine was given, that the refrigerator it was kept in was out of temperature range
More
|
||||||
| 2828049 | 37 | F | ME | 02/25/2025 |
TDAP |
SANOFI PASTEUR |
3CA07C1 |
Exposure during pregnancy, No adverse event, Product storage error
Exposure during pregnancy, No adverse event, Product storage error
|
Out of range temperature for refrigerator. No adverse reactions
Out of range temperature for refrigerator. No adverse reactions
|
||||||
| 2828050 | 21 | F | ME | 02/25/2025 |
TDAP |
SANOFI PASTEUR |
U7904AA |
Exposure during pregnancy, No adverse event, Product storage error
Exposure during pregnancy, No adverse event, Product storage error
|
Out of range temperature for refrigerator. No adverse reactions
Out of range temperature for refrigerator. No adverse reactions
|
||||||
| 2828051 | 16 | F | TX | 02/25/2025 |
HEP HEPA IPV MENB MMR MNQ TDAP VARCEL |
MERCK & CO. INC. MERCK & CO. INC. SANOFI PASTEUR NOVARTIS VACCINES AND DIAGNOSTICS MERCK & CO. INC. SANOFI PASTEUR GLAXOSMITHKLINE BIOLOGICALS MERCK & CO. INC. |
X024135 X025908 W1C831M XX33P X004346 U7827AA H95RD X024649 |
Expired product administered, No adverse event; Expired product administered, No...
Expired product administered, No adverse event; Expired product administered, No adverse event; Expired product administered, No adverse event; Expired product administered, No adverse event; Expired product administered, No adverse event; Expired product administered, No adverse event; Expired product administered, No adverse event; Expired product administered, No adverse event
More
|
Gave an expired MMR vaccine to a child. the MMR vaccine expired 02/08/2025 and it was given on 02/20...
Gave an expired MMR vaccine to a child. the MMR vaccine expired 02/08/2025 and it was given on 02/20/2025. No adverse reactions noted.
More
|
||||||
| 2828052 | 22 | F | ME | 02/25/2025 |
TDAP |
SANOFI PASTEUR |
3CA07C1 |
Exposure during pregnancy, No adverse event, Product storage error
Exposure during pregnancy, No adverse event, Product storage error
|
Out of range temperature for refrigerator. No adverse reaction
Out of range temperature for refrigerator. No adverse reaction
|
||||||
| 2828053 | 27 | F | ME | 02/25/2025 |
TDAP |
SANOFI PASTEUR |
U79529AA |
Exposure during pregnancy, No adverse event, Product storage error
Exposure during pregnancy, No adverse event, Product storage error
|
Out of range temperature for refrigerator. No adverse reactions
Out of range temperature for refrigerator. No adverse reactions
|
||||||
| 2828054 | 35 | F | ME | 02/25/2025 |
TDAP |
SANOFI PASTEUR |
U7929AA |
No adverse event, Product storage error
No adverse event, Product storage error
|
Out of range temperature for refrigerator. No adverse reactions
Out of range temperature for refrigerator. No adverse reactions
|
||||||
| 2828055 | 33 | F | ME | 02/25/2025 |
TDAP |
SANOFI PASTEUR |
u7999aa |
No adverse event, Product storage error
No adverse event, Product storage error
|
Out of range temperature for refrigerator. No adverse reactions
Out of range temperature for refrigerator. No adverse reactions
|
||||||
| 2828056 | 55 | M | WA | 02/25/2025 |
HEP |
DYNAVAX TECHNOLOGIES CORPORATION |
943191 |
Inappropriate schedule of product administration, No adverse event
Inappropriate schedule of product administration, No adverse event
|
Employee given Heplisav-B on 12/4/24 and then again on 12/10/24. No adverse event.
Employee given Heplisav-B on 12/4/24 and then again on 12/10/24. No adverse event.
|
||||||
| 2828057 | 87 | F | ME | 02/25/2025 |
COVID19 |
MODERNA |
031H21A |
Death, Myocardial infarction, Thrombosis
Death, Myocardial infarction, Thrombosis
|
clot developed causing fatal heart attack
clot developed causing fatal heart attack
|
โ | โ | ||||
| 2828058 | 20 | F | ME | 02/25/2025 |
FLU3 |
GLAXOSMITHKLINE BIOLOGICALS |
K9XL5 |
Unevaluable event
Unevaluable event
|
None
None
|
||||||
| 2828059 | 56 | F | 02/25/2025 |
VARZOS VARZOS |
GLAXOSMITHKLINE BIOLOGICALS GLAXOSMITHKLINE BIOLOGICALS |
|
Chills, Dyspnoea, Pain, Pyrexia, Swelling face; Urticaria
Chills, Dyspnoea, Pain, Pyrexia, Swelling face; Urticaria
|
Hives all over body, difficulty breathing, swelling of face, fever, body aches and chills
Hives all over body, difficulty breathing, swelling of face, fever, body aches and chills
|
|||||||
| 2828060 | 74 | F | 02/25/2025 |
COVID19 |
MODERNA |
3043835 |
Computerised tomogram head, Gait inability, Muscular weakness, Musculoskeletal s...
Computerised tomogram head, Gait inability, Muscular weakness, Musculoskeletal stiffness, Pain
More
|
Muscles stiffness, pain, weakness in RUE and RLE. Sevre enough unable to ambulate.
Muscles stiffness, pain, weakness in RUE and RLE. Sevre enough unable to ambulate.
|
|||||||
| 2828061 | 40 | F | ME | 02/25/2025 |
FLU3 |
GLAXOSMITHKLINE BIOLOGICALS |
K9XL5 |
Product storage error
Product storage error
|
It was discovered after the vaccine was given that the refrigerator that it was kept in was out of t...
It was discovered after the vaccine was given that the refrigerator that it was kept in was out of temperature range.
More
|
||||||
| 2828062 | 79 | F | ME | 02/25/2025 |
FLU3 |
SANOFI PASTEUR |
UT8409EA |
Product storage error
Product storage error
|
Patient received a vaccine from a fridge that was out of temperature range at that time.
Patient received a vaccine from a fridge that was out of temperature range at that time.
|
||||||
| 2828064 | 41 | F | ME | 02/25/2025 |
RSV |
PFIZER\WYETH |
LN5502 |
Exposure during pregnancy, Product storage error
Exposure during pregnancy, Product storage error
|
It was discovered after the vaccine was given that the refrigerator that it was kept in was out of t...
It was discovered after the vaccine was given that the refrigerator that it was kept in was out of temperature range.
More
|
||||||
| 2828065 | 37 | F | ME | 02/25/2025 |
RSV TDAP |
PFIZER\WYETH SANOFI PASTEUR |
LN5502 U8231AA |
Exposure during pregnancy, Product storage error; Exposure during pregnancy, Pro...
Exposure during pregnancy, Product storage error; Exposure during pregnancy, Product storage error
More
|
It was discovered after vaccine was given, that the refrigerator it was kept in was out of temperatu...
It was discovered after vaccine was given, that the refrigerator it was kept in was out of temperature range at the time the vaccine was administered.
More
|
||||||
| 2828066 | 43 | F | ME | 02/25/2025 |
COVID19 FLU3 |
MODERNA GLAXOSMITHKLINE BIOLOGICALS |
3043157 DA7P5 |
Unevaluable event; Unevaluable event
Unevaluable event; Unevaluable event
|
None stated.
None stated.
|
||||||
| 2828067 | 1.67 | M | NE | 02/25/2025 |
DTAPHEPBIP |
GLAXOSMITHKLINE BIOLOGICALS |
|
Cardiac monitoring, Dysstasia, Hyporesponsive to stimuli, Seizure, Unresponsive ...
Cardiac monitoring, Dysstasia, Hyporesponsive to stimuli, Seizure, Unresponsive to stimuli
More
|
My son had a seizure and was unresponsive the saturday 2/22/25 after having his Dtap vaccine. We to...
My son had a seizure and was unresponsive the saturday 2/22/25 after having his Dtap vaccine. We took him to the ER and he was responsive by the time we got there but still sluggish and had trouble standing.
More
|
||||||
| 2828068 | 27 | F | ME | 02/25/2025 |
TDAP |
GLAXOSMITHKLINE BIOLOGICALS |
U8231AA |
Product storage error
Product storage error
|
It was discovered after vaccine was given, that the refrigerator it was kept in was out of temperatu...
It was discovered after vaccine was given, that the refrigerator it was kept in was out of temperature range at the time the vaccine was administered.
More
|
||||||
| 2828069 | 17 | F | ME | 02/25/2025 |
FLU3 |
GLAXOSMITHKLINE BIOLOGICALS |
K9XL% |
Exposure during pregnancy, Product storage error
Exposure during pregnancy, Product storage error
|
It was discovered after vaccine was given, that the refrigerator it was kept in was out of temperatu...
It was discovered after vaccine was given, that the refrigerator it was kept in was out of temperature range at the time the vaccine was administered.
More
|
||||||
| 2828070 | 19 | M | ME | 02/25/2025 |
FLU3 |
SEQIRUS, INC. |
K9XL5 |
Product storage error
Product storage error
|
It was discovered after vaccine was given, that the refrigerator it was kept in was out of temperatu...
It was discovered after vaccine was given, that the refrigerator it was kept in was out of temperature range at the time the vaccine was administered.
More
|
||||||
| 2828071 | 36 | F | ME | 02/25/2025 |
HPV9 |
MERCK & CO. INC. |
X019862 |
Product storage error
Product storage error
|
It was discovered after vaccine was given, that the refrigerator it was kept in was out of temperatu...
It was discovered after vaccine was given, that the refrigerator it was kept in was out of temperature range at the time the vaccine was administered.
More
|
||||||
| 2828072 | 11 | F | VA | 02/25/2025 |
HEPA |
GLAXOSMITHKLINE BIOLOGICALS |
22GP3 |
Inappropriate schedule of product administration
Inappropriate schedule of product administration
|
Patient was given Hepatitis A vaccine too early. 2nd dose in series due 6/5/2024, was accidentally ...
Patient was given Hepatitis A vaccine too early. 2nd dose in series due 6/5/2024, was accidentally given today 2/25/2025. Father made aware. He gave verbal understanding.
More
|